The Valley Desk

NCT04377555 · Interventional trial

Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab

Overall registry status Completed

Phase 4

Conditions Multiple Sclerosis, Relapsing

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov